Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review

Kim Hynes, Richard Bright, Susanna Proudman, David Haynes, Stan Gronthos, Mark Bartold

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Background Despite recent advances in the treatment of arthritis with the development of disease-modifying antirheumatic drugs, 30% of patients still fail to respond to treatment. Given the potent anti-inflammatory and immunomodulatory properties of mesenchymal stem cells (MSC) and their ability to repair damaged cartilage, bone, and tendons, it has been proposed that MSC could be ideal for cell-based treatment of arthritis. Objective This systematic review investigates evidence from studies on the therapeutic efficacy of MSC in rodent models of arthritis. Methods PubMed, Embase, MEDLINE, and Wed of Science were searched to June 2015 for quantitative studies examining the outcome of treating animal models of arthritis with MSC. Inclusion criteria were as follows: administration of mesenchymal stem as a treatment approach for arthritis; animal models only; and published in English. We followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Results The literature search identified 30 studies which met the inclusion criteria. A range of MSC populations were assessed in various rodent models of arthritis. Of these, 19 demonstrated positive outcomes while 11 studies failed to demonstrate positive effects. Owing to the extensive variation in the experimental design, cells investigated and the outcome measures described in the manuscripts, no meta-analysis was possible. Furthermore, the numerical values for the primary outcome measure of clinical paw score were frequently not published in the manuscripts analyzed, as they were only illustrated in graphical form. Conclusions Numerous studies have investigated the utility of a range of MSC populations in the treatment of experimental arthritis. The results obtained from these studies have been highly inconsistent, with multiple studies identifying a statistically significant improvement in arthritis scores after treatment with MSC, while other studies identified a statistically significant deterioration in arthritis scores and thirdly some studies showed no effect. Further studies using standardized protocols and outcome measures are needed to determine fully the potential of MSC populations in the treatment of experimental arthritis.

LanguageEnglish
Pages1-19
Number of pages19
JournalSeminars in Arthritis and Rheumatism
Volume46
Issue number1
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • Anti-inflammatory
  • Arthritis
  • Cell therapy
  • Immunomodulation
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine

Cite this

Hynes, Kim ; Bright, Richard ; Proudman, Susanna ; Haynes, David ; Gronthos, Stan ; Bartold, Mark. / Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models : A systematic review. In: Seminars in Arthritis and Rheumatism. 2016 ; Vol. 46, No. 1. pp. 1-19.
@article{8a247d438ec9446cafe17b806b50c902,
title = "Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review",
abstract = "Background Despite recent advances in the treatment of arthritis with the development of disease-modifying antirheumatic drugs, 30{\%} of patients still fail to respond to treatment. Given the potent anti-inflammatory and immunomodulatory properties of mesenchymal stem cells (MSC) and their ability to repair damaged cartilage, bone, and tendons, it has been proposed that MSC could be ideal for cell-based treatment of arthritis. Objective This systematic review investigates evidence from studies on the therapeutic efficacy of MSC in rodent models of arthritis. Methods PubMed, Embase, MEDLINE, and Wed of Science were searched to June 2015 for quantitative studies examining the outcome of treating animal models of arthritis with MSC. Inclusion criteria were as follows: administration of mesenchymal stem as a treatment approach for arthritis; animal models only; and published in English. We followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Results The literature search identified 30 studies which met the inclusion criteria. A range of MSC populations were assessed in various rodent models of arthritis. Of these, 19 demonstrated positive outcomes while 11 studies failed to demonstrate positive effects. Owing to the extensive variation in the experimental design, cells investigated and the outcome measures described in the manuscripts, no meta-analysis was possible. Furthermore, the numerical values for the primary outcome measure of clinical paw score were frequently not published in the manuscripts analyzed, as they were only illustrated in graphical form. Conclusions Numerous studies have investigated the utility of a range of MSC populations in the treatment of experimental arthritis. The results obtained from these studies have been highly inconsistent, with multiple studies identifying a statistically significant improvement in arthritis scores after treatment with MSC, while other studies identified a statistically significant deterioration in arthritis scores and thirdly some studies showed no effect. Further studies using standardized protocols and outcome measures are needed to determine fully the potential of MSC populations in the treatment of experimental arthritis.",
keywords = "Anti-inflammatory, Arthritis, Cell therapy, Immunomodulation, Mesenchymal stem cells",
author = "Kim Hynes and Richard Bright and Susanna Proudman and David Haynes and Stan Gronthos and Mark Bartold",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.semarthrit.2016.02.008",
language = "English",
volume = "46",
pages = "1--19",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models : A systematic review. / Hynes, Kim; Bright, Richard; Proudman, Susanna; Haynes, David; Gronthos, Stan; Bartold, Mark.

In: Seminars in Arthritis and Rheumatism, Vol. 46, No. 1, 01.08.2016, p. 1-19.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models

T2 - Seminars in Arthritis and Rheumatism

AU - Hynes, Kim

AU - Bright, Richard

AU - Proudman, Susanna

AU - Haynes, David

AU - Gronthos, Stan

AU - Bartold, Mark

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background Despite recent advances in the treatment of arthritis with the development of disease-modifying antirheumatic drugs, 30% of patients still fail to respond to treatment. Given the potent anti-inflammatory and immunomodulatory properties of mesenchymal stem cells (MSC) and their ability to repair damaged cartilage, bone, and tendons, it has been proposed that MSC could be ideal for cell-based treatment of arthritis. Objective This systematic review investigates evidence from studies on the therapeutic efficacy of MSC in rodent models of arthritis. Methods PubMed, Embase, MEDLINE, and Wed of Science were searched to June 2015 for quantitative studies examining the outcome of treating animal models of arthritis with MSC. Inclusion criteria were as follows: administration of mesenchymal stem as a treatment approach for arthritis; animal models only; and published in English. We followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Results The literature search identified 30 studies which met the inclusion criteria. A range of MSC populations were assessed in various rodent models of arthritis. Of these, 19 demonstrated positive outcomes while 11 studies failed to demonstrate positive effects. Owing to the extensive variation in the experimental design, cells investigated and the outcome measures described in the manuscripts, no meta-analysis was possible. Furthermore, the numerical values for the primary outcome measure of clinical paw score were frequently not published in the manuscripts analyzed, as they were only illustrated in graphical form. Conclusions Numerous studies have investigated the utility of a range of MSC populations in the treatment of experimental arthritis. The results obtained from these studies have been highly inconsistent, with multiple studies identifying a statistically significant improvement in arthritis scores after treatment with MSC, while other studies identified a statistically significant deterioration in arthritis scores and thirdly some studies showed no effect. Further studies using standardized protocols and outcome measures are needed to determine fully the potential of MSC populations in the treatment of experimental arthritis.

AB - Background Despite recent advances in the treatment of arthritis with the development of disease-modifying antirheumatic drugs, 30% of patients still fail to respond to treatment. Given the potent anti-inflammatory and immunomodulatory properties of mesenchymal stem cells (MSC) and their ability to repair damaged cartilage, bone, and tendons, it has been proposed that MSC could be ideal for cell-based treatment of arthritis. Objective This systematic review investigates evidence from studies on the therapeutic efficacy of MSC in rodent models of arthritis. Methods PubMed, Embase, MEDLINE, and Wed of Science were searched to June 2015 for quantitative studies examining the outcome of treating animal models of arthritis with MSC. Inclusion criteria were as follows: administration of mesenchymal stem as a treatment approach for arthritis; animal models only; and published in English. We followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Results The literature search identified 30 studies which met the inclusion criteria. A range of MSC populations were assessed in various rodent models of arthritis. Of these, 19 demonstrated positive outcomes while 11 studies failed to demonstrate positive effects. Owing to the extensive variation in the experimental design, cells investigated and the outcome measures described in the manuscripts, no meta-analysis was possible. Furthermore, the numerical values for the primary outcome measure of clinical paw score were frequently not published in the manuscripts analyzed, as they were only illustrated in graphical form. Conclusions Numerous studies have investigated the utility of a range of MSC populations in the treatment of experimental arthritis. The results obtained from these studies have been highly inconsistent, with multiple studies identifying a statistically significant improvement in arthritis scores after treatment with MSC, while other studies identified a statistically significant deterioration in arthritis scores and thirdly some studies showed no effect. Further studies using standardized protocols and outcome measures are needed to determine fully the potential of MSC populations in the treatment of experimental arthritis.

KW - Anti-inflammatory

KW - Arthritis

KW - Cell therapy

KW - Immunomodulation

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84963815391&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2016.02.008

DO - 10.1016/j.semarthrit.2016.02.008

M3 - Review article

VL - 46

SP - 1

EP - 19

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 1

ER -